These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1349806)

  • 1. Cost of beta-adrenergic receptor blocking agents for ocular hypertension.
    Ball SF; Schneider E
    Arch Ophthalmol; 1992 May; 110(5):654-7. PubMed ID: 1349806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily cost of beta-adrenergic blocker therapy.
    Stewart WC; Sine C; Cate E; Minno GE; Hunt HH
    Arch Ophthalmol; 1997 Jul; 115(7):853-6. PubMed ID: 9230824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapy cost considerations for glaucoma.
    Fiscella RG; Green A; Patuszynski DH; Wilensky J
    Am J Ophthalmol; 2003 Jul; 136(1):18-25. PubMed ID: 12834665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost considerations of medical therapy for glaucoma.
    Fiscella RG; Geller JL; Gryz LL; Wilensky J; Viana M
    Am J Ophthalmol; 1999 Oct; 128(4):426-33. PubMed ID: 10577583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of annual cost between brand and generic ocular beta-adrenergic blockers].
    Ikeda H; Tsukamoto H; Sawa A; Sugimoto A; Mishima H; Kihira K
    Yakugaku Zasshi; 2005 May; 125(5):463-7. PubMed ID: 15863979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectivity analysis of the most used antiglaucoma drugs].
    Galindo-Ferreiro A; Sánchez-Tocino H; Fernández-Muñoz M; Iglesias Cortiñas D
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):379-84. PubMed ID: 15306964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of glaucoma medications.
    Vold SD; Wiggins DA; Jackimiec J
    J Glaucoma; 2000 Apr; 9(2):150-3. PubMed ID: 10782624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily cost of ophthalmic solutions for treating glaucoma in Japan.
    Ikeda H; Sato E; Kitaura T; Fukuchi H; Kimura Y; Kihira K
    Jpn J Ophthalmol; 2001; 45(1):99-102. PubMed ID: 11163052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of glaucoma medications.
    Rylander NR; Vold SD
    Am J Ophthalmol; 2008 Jan; 145(1):106-13. PubMed ID: 18154755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily cost of glaucoma medications in China.
    Gao Y; Wu L; Li A
    J Glaucoma; 2007; 16(7):594-7. PubMed ID: 18091176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
    Queen JH; Feldman RM; Lee DA
    Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension.
    Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S240-8. PubMed ID: 12188166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily cost of ophthalmic solutions used to treat allergic conjunctivitis in Japan.
    Ikeda H; Tsukamoto H; Sato E; Mishima HK; Kihira K
    Ophthalmic Epidemiol; 2004 Feb; 11(1):35-42. PubMed ID: 14977495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single dose administration in therapy of glaucoma. Comparison of costs with multiple dose].
    Hertel F; Pfeiffer N
    Ophthalmologe; 1994 Oct; 91(5):602-5. PubMed ID: 7812091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic versus brand-name North American topical glaucoma drops.
    Mammo ZN; Flanagan JG; James DF; Trope GE
    Can J Ophthalmol; 2012 Feb; 47(1):55-61. PubMed ID: 22333853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost analysis of the prostaglandin analogs.
    Mick AB; Gonzalez S; Dunbar MT; McSoley JJ
    Optometry; 2002 Oct; 73(10):614-9. PubMed ID: 12408547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.
    Day DG; Schacknow PN; Sharpe ED; Ellyn JC; Kulze JC; Threlkeld AB; Jones ED; Brown RH; Jenkins JN; Stewart WC
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):383-92. PubMed ID: 15650513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of administration angle on the cost of artificial tear solutions: does bottle positioning minimize wastage?
    Gaynes BI; Singa RM; Schaab G; Sorokin Y
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):196-201. PubMed ID: 17444808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage cost analysis in glaucoma management.
    Gelvin JB; Goen TM
    J Am Optom Assoc; 1989 Oct; 60(10):768-70. PubMed ID: 2584592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.